Has Kevin Kelley, MD received payments from drug or device companies?

Yes. Drug and device makers reported $450 in general payments to Kevin Kelley, MD across 32 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Kevin Kelley, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Kevin Kelley, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Kevin Kelley, MD

Nephrology · Canton, OHNPI 1982600979

Payments from drug & device makers

$450in general payments, 2019–2025

Across 32 payments — averaging $14.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Amgen$67
Sanofi$51
Fresenius USA Marketing, Inc.$48
Vifor Pharma, Inc.$46
Calliditas Therapeutics US Inc.$39
Mallinckrodt Hospital Products Inc.$36
plus $163 from 9 others

What the payments were for

Food & beverage$41392%
Education$388%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Amgen	3	$67
Sanofi	3	$51
Fresenius USA Marketing, Inc.	3	$48
Vifor Pharma, Inc.	3	$46
Calliditas Therapeutics US Inc.	2	$39
Mallinckrodt Hospital Products Inc.	1	$36
Baxter Healthcare	2	$31
Boston Scientific	1	$19
Akebia Therapeutics Inc	1	$19
Otsuka America Pharmaceutical, Inc.	1	$18
Travere Therapeutics, Inc.	8	$18
AstraZeneca	1	$17
Aurinia Pharma U.S., Inc.	1	$15
Daiichi Sankyo Inc.	1	$15
AMAG Pharmaceuticals, Inc.	1	$13

How this compares

$450 in reported general payments places this provider in the 30th percentile of 450 nephrology providers in Ohio.

See all nephrology providers in Ohio →

Medicare billing

Part B allowed, 2024

$224,843

Medicare patients

356

Services billed

2,801

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Tiopronin	12	$45,815
Clonidine	18	$2,840
Doxazosin Mesylate	137	$2,443
Bumetanide	86	$2,285
Losartan Potassium	223	$2,269
Calcitriol	122	$2,020
Sevelamer Carbonate	20	$1,916
Amlodipine Besylate	297	$1,664
Valsartan	25	$1,358
Hydralazine Hcl	67	$1,258
Furosemide	269	$1,076
Carvedilol	77	$928
Cinacalcet Hcl	22	$843
Calcium Acetate	21	$794
Tamsulosin Hcl	37	$619

Paid to pharmacies, not to this prescriber.

Other nephrology in Canton

James RajanCanton$184K
Bhavnish BucktowarsingCanton$70K
Isabelle AyoubColumbus$1.6M
Andrew LazarBeachwood$806K
Samir ParikhColumbus$699K
Brad RovinColumbus$625K
Lance DworkinToledo$601K
Mohamed SekkarieToledo$524K
Kevin SchroederColumbus$518K
Prabir Roy ChaudhuryCincinnati$483K

See the full list for Ohio →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →